NCT00501566 - Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites | Biotech Hunter

Enrollment

148

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

January 31, 2005

Conditions

AscitesLiver Cirrhosis

Interventions

DRUG

satavaptan (SR121463B)

Trial Locations (12)

Sanofi-Aventis Administrative Office, Buenos Aires

Sanofi-Aventis Administrative Office, Cove

Sanofi-Aventis Administrative Office, Diegem

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Zagreb

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Budapest

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, Bucharest

Sanofi-Aventis Administrative Office, Barcelona